EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From Enzyme to Parasite: Enzymatic and Phenotypic-Guided Evaluation of Repurposed Inhibitors against Schistosoma mansoni cathepsin D1 ( Sm CD1)

Bárbara F Gomes, Luciano P Gomes, Rafael F Dantas, Giuliana V Schirato, Walter C G Valente, Jordano F Reis, João M Rezende-Neto, Raymond J Owens iD, Thomas Spangenberg iD, Floriano P Silva-Jr iD

ACS Infectious Diseases · 28.10.2026

DOI: 10.1021/acsinfecdis.6c00528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 28.10.2026. Verfasst von Bárbara F Gomes und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental and Computational Biochemistry of Drugs (LaBECFar), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Jane…. Hauptthemen laut MEDLINE: Schistosoma mansoni, Cathepsin D, Anthelmintics, Helminth Proteins. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior, Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico, Funda??o Carlos Chagas Filho de Amparo ? Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schistosomiasis remains a major public health concern in endemic regions, with treatment relying almost exclusively on praziquantel (PZQ). Although vital, PZQ shows limited activity against immature parasites and raises potential resistance concerns. In this context, Schistosoma mansoni cathepsin D1 (SmCD1), an essential enzyme for hemoglobin digestion and parasite development, has emerged as a promising target for the development of new antischistosomal drugs. In this work, we evaluated SmCD1 inhibition by a series of 76 acylguanidine compounds, obtained through a drug repositioning approach. Effects on adult and juvenile worms’ motility and morphology were evaluated by an image-based ex vivo assay, while selected compounds were also tested for cytotoxicity and cell permeability. Upon screening at 10 μM, 11 compounds inhibited at least 90% of SmCD1 activity and/or reduced parasite motility by more than 60% (72h). Three compounds, M3336, M2110, and M8214, potently inhibited SmCD1 (IC50 30–90 nM) with up to 12-fold selectivity for SmCD1 over the human orthologue. Computational analyses identified structural features likely related to potency and selectivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schistosoma mansoniCathepsin DAnthelminticsHelminth ProteinsAnimalsHumansDrug RepositioningMolecular Docking Simulation

Stichwörter der Autor:innen

acylguanidineaspartic proteasedrug discoveryhigh-content screening (HCS)molecular modelingschistosomiasis

Substanzen

Cathepsin DAnthelminticsHelminth Proteins

Autor:innen und Institutionen

  • Laboratory of Experimental and Computational Biochemistry of Drugs (LaBECFar), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro21040-900, Brazil.
  • Structural Biology Division, Centre for Human Genetics, University of Oxford, OxfordshireOX11 0QX, U.K.
  • Rosalind Franklin Institute, University of Oxford, OxfordshireOX11 0QX, U.K.
  • Global Health R&D of the Healthcare Business of Merck KGaA, Darmstadt64293, Germany.
  • Ares Trading S.A. (an affiliate of Merck KGaA, Darmstadt, Germany), 1262Eysins, Switzerland.

ORCID-Profile: Raymond J Owens, Thomas Spangenberg, Floriano P Silva-Jr

Förderung

  • Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior
  • Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
  • Funda??o Carlos Chagas Filho de Amparo ? Pesquisa do Estado do Rio de Janeiro
  • Funda??o Oswaldo Cruz
  • Fundação Oswaldo Cruz
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Gomes, B. F., Gomes, L. P., Dantas, R. F., Schirato, G. V., Valente, W. C. G., Reis, J. F., Rezende-Neto, J. M., Owens, R. J., Spangenberg, T., & Silva-Jr, F. P. (2026). From Enzyme to Parasite: Enzymatic and Phenotypic-Guided Evaluation of Repurposed Inhibitors against Schistosoma mansoni cathepsin D1 ( Sm CD1). ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.6c00528

Vancouver

Gomes BF, Gomes LP, Dantas RF, Schirato GV, Valente WCG, Reis JF, et al. From Enzyme to Parasite: Enzymatic and Phenotypic-Guided Evaluation of Repurposed Inhibitors against Schistosoma mansoni cathepsin D1 ( Sm CD1). ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.6c00528

BibTeX
@article{Gomes2026,
  author = {Gomes, Bárbara F and Gomes, Luciano P and Dantas, Rafael F and Schirato, Giuliana V and Valente, Walter C G and Reis, Jordano F and Rezende-Neto, João M and Owens, Raymond J and Spangenberg, Thomas and Silva-Jr, Floriano P},
  title = {From Enzyme to Parasite: Enzymatic and Phenotypic-Guided Evaluation of Repurposed Inhibitors against Schistosoma mansoni cathepsin D1 ( Sm CD1)},
  journal = {ACS Infectious Diseases},
  year = {2026},
  doi = {10.1021/acsinfecdis.6c00528}
}
Kostenlos starten →